wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47732809-124A1B2D-F469-4D21-87A1-F5A64AE55C2C
Q47732809-124A1B2D-F469-4D21-87A1-F5A64AE55C2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47732809-124A1B2D-F469-4D21-87A1-F5A64AE55C2C
Biomimetic microfluidic platform for the quantification of transient endothelial monolayer permeability and therapeutic transport under mimicked cancerous conditions.
P2860
Q47732809-124A1B2D-F469-4D21-87A1-F5A64AE55C2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47732809-124A1B2D-F469-4D21-87A1-F5A64AE55C2C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4a4356540ac2f48aea05a20acc24529724f31ef5
P2860
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.